Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection

Published:2016-07-04 Issue:12 Volume:17 Page:1669-1682
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Blasco H¹²³,Patin F¹²³,Andres CR¹²³,Corcia P¹²⁴,Gordon PH⁵

Affiliation:

1. Inserm U930, Equipe “neurogénétique et neurométabolomique“, Tours, France

2. Université François-Rabelais, Faculté de Médecine, Tours, France

3. Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Tours, Tours, France

4. Centre SLA, Service de Neurologie, CHRU Bretonneau, Tours, France

5. Northern Navajo Medical Center, Neurology Unit, Shiprock, NM, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2016.1202919

Reference184 articles.

1. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

2. Use of biomarkers in ALS drug development and clinical trials

3. Deciphering spreading mechanisms in amyotrophic lateral sclerosis

4. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway;Neurology Research International;2022-04-12

2. Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis;Biomedicines;2021-12-18

3. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia;Clinics in Laboratory Medicine;2020-09

4. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2020-06-23

5. Modulating ALS-Related Amyloidogenic TDP-43307–319 Oligomeric Aggregates with Computationally Derived Therapeutic Molecules;Biochemistry;2019-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3